University Of California, San Francisco

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Philippine Child Health and Policy Experiment

Not Applicable

Completed

Conditions: Childhood Illness

Interventions: Other: Bonus/Pay-for-Performance Intervention
Other: Access Intervention

First Posted Date: 2008-05-15

Last Posted Date: 2015-05-04

Lead Sponsor: University of California, San Francisco

Registration Number: NCT00678197

Effect of Endothelin-1 Receptor Blockade on Circulating Endothelial Microparticles Levels in Patients With Pulmonary Hypertension

Completed

Conditions: Pulmonary Hypertension

First Posted Date: 2008-05-08

Last Posted Date: 2016-10-27

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 20

Registration Number: NCT00675051

Locations: 🇺🇸
University of California, San Francisco, California, United States

Raltegravir Augmentation on Persistent Central Nervous System (CNS) Immunoactivation in Treated HIV-1 Patients

Not Applicable

Completed

Conditions: HIV Infections

Interventions: Drug: raltegravir

First Posted Date: 2008-05-06

Last Posted Date: 2013-07-05

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 18

Registration Number: NCT00672932

Locations: 🇺🇸
Ucsf Ccrc, Sfgh, San Francisco, California, United States

Prenatal Steroids for Treatment of Congenital Cystic Adenomatoid Malformations (CCAM)

Phase 1

Terminated

Conditions: Congenital Cystic Adenomatoid Malformation

Interventions: Drug: Placebo
Drug: Betamethasone

First Posted Date: 2008-05-02

Last Posted Date: 2015-03-30

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 1

Registration Number: NCT00670956

Locations: 🇺🇸
University of California, San Francisco Fetal Treatment Center, San Francisco, California, United States
🇺🇸
Cincinnati Children's Hospital, Cincinnati, Ohio, United States
🇺🇸
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

Weight-Bearing Magnetic Resonance Imaging (MRI) for Analysis of Knee Osteoarthritis (OA)

Completed

Conditions: Osteoarthritis

Interventions: Radiation: X-ray; magnetic resonance imaging

First Posted Date: 2008-04-24

Last Posted Date: 2009-04-17

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 33

Registration Number: NCT00665548

Locations: 🇺🇸
University of California - San Francisco, San Francisco, California, United States

Entecavir Intensification for Persistent HBV Viremia in HIV-HBV Infection

Phase 4

Completed

Conditions: HIV Infections
Hepatitis B

Interventions: Drug: Entecavir with continued standard of care antiretroviral therapy
Drug: continued standard of care with tenofovir in addition to emtricitabine or lamivudine

First Posted Date: 2008-04-21

Last Posted Date: 2013-05-27

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 10

Registration Number: NCT00662545

Locations: 🇺🇸
San Francisco General HIV Clinical Trials Group, San Francisco, California, United States

Impact of Extensive Consultation on Career Development Grant Outcomes

Not Applicable

Completed

Conditions: Career Development Grant Outcomes

Interventions: Other: Extensive Consultations

First Posted Date: 2008-04-21

Last Posted Date: 2018-10-11

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 132

Registration Number: NCT00662402

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Effect of Timi3 Ultrasound on Myocardial Blow Flow in the Hibernating Myocardium

Early Phase 1

Terminated

Conditions: Myocardial Ischemia

First Posted Date: 2008-04-09

Last Posted Date: 2012-04-04

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 9

Registration Number: NCT00655070

Locations: 🇺🇸
UC San Francisco, San Francisco, California, United States

Mechanisms of Metabolic Regulation of Resveratrol on Humans With Metabolic Syndrome

Phase 2

Withdrawn

Conditions: Insulin Resistance

Interventions: Drug: Placebo
Drug: Resveratrol

First Posted Date: 2008-04-09

Last Posted Date: 2015-03-04

Lead Sponsor: University of California, San Francisco

Registration Number: NCT00654667

Locations: 🇺🇸
University of California, San Francisco, California, United States

Effectiveness of Neuroadaptive Cognitive Training in Adolescents at Risk for Psychosis

Not Applicable

Completed

Conditions: Schizophrenia

Interventions: Behavioral: Computer games
Behavioral: Neuroadaptive cognitive training

First Posted Date: 2008-04-09

Last Posted Date: 2019-01-08

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 143

Registration Number: NCT00655239

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy